Regulatory Requirements for Drug Safety & Pharmacovigilance – Online Training Event, August 20, 2025: Stay Compliant Across US, EU, and UK – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Regulatory Requirements for Drug Safety & Pharmacovigilance (August 20, 2025)” online training has... Read more.
Stonepeak Launches European Renewable Land Aggregation Platform JouleTerra
Investments in Electric Land and Solaria’s Generia Land represent the Platform’s inaugural transactions NEW YORK–(BUSINESS WIRE)–Stonepeak, a leading... Read more.
Repairify Expands Sales Leadership Team, Announces Hiring of New Vice President of Sales, Additional Sales Team Promotions
New team will focus on customer-first initiatives to drive value and support long-term growth DALLAS–(BUSINESS WIRE)–Repairify, the global leader in... Read more.
Paragonix to Spotlight Breakthrough Research in Solid Organ Transplantation at the 2025 World Transplant Congress
Presentations at WTC 2025 will highlight real-world data and clinical innovations in solid organ preservation using Paragonix advanced hypothermic preservation and... Read more.
Stonepeak to Invest in Electric Land
NEW YORK & LONDON–(BUSINESS WIRE)–Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced... Read more.
Stonepeak Acquires Interest in Solaria’s Generia Land
Investment to allow Generia Land to make additional land acquisitions and position it to become one of the largest renewable land companies in Europe NEW YORK &... Read more.
Fable Security Launches With $31M to Stop Risky Human Behavior
Combining AI and behavioral science, Fable sets fire to old playbook with human risk platform that actually delivers results SAN FRANCISCO–(BUSINESS WIRE)–Fable... Read more.
Tractor Supply Named Exclusive National Retailer for SmartEquine SmartPaks Leading Equine Supplement System
SmartEquine products are now available nationwide in stores and online, with SmartPaks pre-portioned supplement packs designed for essential equine wellness available... Read more.
Genethon to Launch Pivotal Trial in Europe of GNT0004 a Low-Dose Microdystrophin Gene Therapy for Duchenne Muscular Dystrophy
Phase 3 trial clearance is based on the Phase 1/2 results demonstrating safety and efficacy of the 3×10¹³ vg/kg dose of microdystrophin, which is lower than... Read more.
Africa Prefabricated Construction Market Databook 2025 | Public-Private Partnerships Fuel Prefabricated Housing Initiatives Across Africa – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Africa Prefabricated Construction Market Intelligence and Future Growth Dynamics Databook – 100+ KPIs, Market... Read more.